CERE: Cerevel Therapeutics Holdings, Inc. Stock

by  •  • Comments Off on CERE: Cerevel Therapeutics Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7,680.69
Enterprise Value ($M) 7,812.17
Book Value ($M) 564.46
Book Value / Share 3.11
Price / Book 13.61
NCAV ($M) 296.69
NCAV / Share 1.63
Price / NCAV 25.89

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.49
Return on Equity (ROE) -1.07

Liquidity (mrq)
Quick Ratio 10.22
Current Ratio 10.22

Balance Sheet (mrq) ($M)
Current Assets 859.58
Assets 1,127.34
Liabilities 562.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -447.26
Net Income -432.84
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -342.30
Cash from Investing 73.72
Cash from Financing 548.62

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A Fmr Llc 0.29 -94.60
12-08 13D/A BC Perception Holdings, LP 36.40 0.00
10-18 13D/A Pfizer Inc 15.40 0.00
10-17 13D/A Perceptive Advisors Llc 6.20 8.69

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1)
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-19 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ T

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 49,357 156,830 31.47
2024-05-09 213,057 194,212 109.70
2024-05-08 261,349 235,600 110.93

(click for more detail)

Similar Companies
CDXC – ChromaDex Corporation CELU – Celularity Inc.
CELZ – Creative Medical Technology Holdings, Inc. CGEN – Compugen Ltd.
CING – Cingulate Inc.


Financial data and stock pages provided by
Fintel.io